Stabilized preparations for use in metered dose inhalers
AssigneeInhale Therapeutic Systems
InventorsJeffry G. Weers, Ernest G. Schutt, Luis A. Dellamary, Thomas E. Tarara, Alexey Kabalnov
Life of this patent
Estimating the term…
Loading patent…
AssigneeInhale Therapeutic Systems
InventorsJeffry G. Weers, Ernest G. Schutt, Luis A. Dellamary, Thomas E. Tarara, Alexey Kabalnov
Estimating the term…
Stabilized dispersions are provided for the delivery of a bioactive agent to the respiratory tract of a patient. The dispersions preferably comprise a plurality of perforated microstructures dispersed in a suspension medium that typically comprises a hydrofluoroalkane propellant. As density variations between the suspended particles and suspension medium are minimized and attractive forces between microstructures are attenuated, the disclosed dispersions are particularly resistant to degradation, such as, by settling or flocculation. In particularly preferred embodiments, the stabilized dispersions may be administered to the lung of a patient using a metered dose inhaler.
A stable respiratory dispersion for the pulmonary delivery of one or more bioactive agents comprising a suspension medium having dispersed therein a plurality of perforated microstructures having a mean aerodynamic diameter of less than 5 μm and comprising at least one bioactive agent wherein said suspension medium comprises at least one propellant and substanially permeates said perforated microstructures wherein more than 30% of the average particle volume of the perforated microstructures is permeated by said suspension medium.
A method for forming a stabilized respiratory dispersion comprising the steps of:
The method of claim wherein said propellant comprises a hydrofluoroalkane propellant.
A method for stabilizing a dispersion by reducing attractive van der Waals forces comprising
A respiratory dispersion for the pulmonary delivery of one or more bioactive agents comprising a suspension medium having dispersed therein a plurality of microparticles having a mean aerodynamic diameter of less than 5 μm and comprising greater than about 20% w/w surfactant and at least one bioactive agent wherein said suspension medium comprises at least one propellant.
Dependencies are inferred from the claim text.